Conclusion. Ceftobiprole is a novel, broad-spectrum, parenteral cephalosporin undergoing Phase III clinical trials. Its broad spectrum of activity makes it a candidate for monotherapy of cSSSIs ...

For further clarification, consult your healthcare provider. This medication is a broad-spectrum cephalosporin antibiotic, prescribed for serious infections such as respiratory tract infection ...